Abstract
Noonan syndrome (NS) is a genetic condition characterized by congenital heart defects, short stature and characteristic facial features. We here present the case of a girl with moderate learning disabilities, delayed language development, craniofacial features and skin anomalies reminiscent of NS. After a mutation screening of the known NS genes PTPN11, SOS1, RAF1, KRAS, GRB2, BRAF and SHOC2 we found the heterozygous c.755T>C variant in SOS1 causing the p.I252T amino-acid substitution, which was considered possibly pathogenetic by bioinformatic predictions. The same variant was present in the proband’s mother, displaying some NS features, and maternal grandfather showing no NS traits, but also by a healthy subject in 1000 genomes project database without phenotype informations. The functional analysis revealed that SOS1 c.755C activated the RAS-ERK intracellular pathway, whereas no effects on RAC-JNK cascade have been detected. After a comparison between the sequence of SOS1 cDNA from peripheral blood and SOS1 genomic DNA, we showed for the first time a differential allelic expression of the SOS1 gene in healthy individuals, thus occurring as a physiologic condition. Interestingly, we found that the mutated allele C was 50% more expressed than the wild-type allele T in all familial carriers. The comparable amount of SOS1 mRNA between mutated individuals and the controls indicates that the variant does not affect SOS1 expression. The present study provides a first evidence of allelic imbalance of SOS1 and pinpoints this condition as a possible mechanism underlying a different penetrance of some SOS1-mutated alleles in unrelated carriers.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Tartaglia M, Zampino G, Gelb BD : Noonan syndrome: clinical aspects and molecular pathogenesis. Mol Syndromol 2010; 1: 2–26.
van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E : Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet 1994; 53: 187–191.
Rauen KA : The RASopayhies. Annu Rev Genomics Hum Genet 2013; 14: 355–369.
Brems H, Pasmant E, Van Minkelen R et al: Review and update of SPRED1 mutations causing Legius syndrome. Hum Mutat 2012; 33: 1538–1546.
Martinelli S, De Luca A, Stellacci E et al: Heterozygous germline mutations in the CBL tumor supressor gene cause a Noonan syndrome-like phenotype. Am J Hum Genet 2010; 15: 250–257.
Aoki Y, Niihori T, Banjo T et al: Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. Am J Hum Genet 2013; 93: 173–180.
Flex E, Jaiswal M, Pantaleoni F et al: Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis. Hum Mol Genet 2014; 23: 4315–4327.
Lepri F, De Luca A, Stella L et al: SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations. Hum Mutat 2011; 32: 760–772.
Tartaglia M, Gelb BD : Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet 2005; 6: 45–68.
Tartaglia M, Pennacchio LA, Zhao C et al: Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 2007; 39: 75–79.
Longoni M, Moncini S, Cisternino M et al: Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations. Am J Med Genet A 2010; 152A: 2176–2184.
Pandit B, Sarkozy A, Pennacchio LA et al: Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 2007; 39: 1007–1012.
Roberts AE, Araki T, Swanson KD et al: Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 2007; 39: 70–74.
Innocenti M, Zippel R, Brambilla R, Sturani E : CDC25(Mm)/Ras-GRF1 regulates both Ras and Rac signaling pathways. FEBS Lett 1999; 460: 357–362.
Pierre S, Bats AS, Coumoul X : Understanding SOS (Son of Sevenless). Biochem Pharmacol 2011; 82: 1049–1056.
Sondermann H, Soisson SM, Boykevisch S, Yang SS, Bar-Sagi D, Kuriyan J : Structural analysis of autoinhibition in the Ras activator Son of Sevenless. Cell 2004; 119: 393–405.
Smith MJ, Neel BG, Ikura M : NMR-based functional profiling of RASopathies and oncogenic RAS mutations. Proc Natl Acad Sci U S A 2013; 110: 4574–4579.
Serre D, Gurd S, Ge B et al: Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet 2008; 4: e1000006.
Lv Z, Yang L : MiR-124 inhibits the growth of glioblastoma through the downregulation of SOS1. Mol Med Rep 2013; 8: 345–349.
Wilkins JM, Southam L, Price AJ, Mustafa Z, Carr A, Loughlin J : Extreme context specificity in differential allelic expression. Hum Mol Genet 2007; 16: 537–546.
Burkhardt J, Kirsten H, Wolfram G, Quente E, Ahnert P : Differential allelic expression of IL13 and CSF2 genes associated with asthma. Genet Mol Biol 2012; 35: 567–574.
Ayala FJ, Escalante A, O’Huigin C, Klein J : Molecular genetics of speciation and human origins. Proc Natl Acad Sci USA 1994; 91: 6787–6794.
Rockman MV, Wray GA : Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol 2002; 19: 1991–2004.
Kleinjan DA, van Heyningen V : Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 2005; 76: 8–32.
Liu J, Francke U : Identification of cis-regulatory elements for MECP2 expression. Hum Mol Genet 2006; 15: 1769–1782.
Jentarra GM, Rice SG, Olfers S, Rajan C, Saffen DM, Narayanan V : Skewed allele-specific expression of the NF1 gene in normal subjects: a possible mechanism for phenotypic variability in neurofibromatosis type 1. J Child Neurol 2012; 27: 695–702.
Acknowledgements
We thank Dr Milena Crippa and Dr Valeria Rimoldi for their technical support. This study was supported by an academic fund for basic research (Programma dell’Università per la Ricerca PUR to PR).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on European Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Moncini, S., Bonati, M., Morella, I. et al. Differential allelic expression of SOS1 and hyperexpression of the activating SOS1 c.755C variant in a Noonan syndrome family. Eur J Hum Genet 23, 1531–1537 (2015). https://doi.org/10.1038/ejhg.2015.20
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2015.20
This article is cited by
-
Creation of miniature pig model of human Waardenburg syndrome type 2A by ENU mutagenesis
Human Genetics (2017)
